Pharmaceuticals
The Pharmaceuticals Division of Novartis is recognized worldwide for the innovative medicines we provide to patients, physicians and healthcare organizations. This growing business develops and markets patent-protected prescription drugs for important health needs. Our products are concentrated in major therapeutic areas including:
Immunology and Infectious Diseases
The current product portfolio includes more than 50 key marketed products, many of which are leaders in their respective therapeutic areas. In 2008, Novartis launched 11 products in the United States and Europe.
The product development pipeline has 148 projects in various stages of clinical development, including potential new products as well as potential new indications or formulations for existing products.
Innovative medicines
Research
Novartis is one of the industry’s biggest investors in research.